Matthew V. Grumbling

Array ( [id] => 3997391 [patent_doc_number] => 05922706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Morpholine and thiomorpholine tachykinin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/969685 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74584 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 2236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922706.pdf [firstpage_image] =>[orig_patent_app_number] => 969685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745397 [patent_doc_number] => 05801242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Process for making quinolonyl lactam antimicrobials and novel intermediate compounds' [patent_app_type] => 1 [patent_app_number] => 8/968987 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28133 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2381 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801242.pdf [firstpage_image] =>[orig_patent_app_number] => 968987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997482 [patent_doc_number] => 05922711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => '8-substituted quinazolines, quinoxalines and benzopyridazines' [patent_app_type] => 1 [patent_app_number] => 8/933354 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88538 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922711.pdf [firstpage_image] =>[orig_patent_app_number] => 933354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983775 [patent_doc_number] => 05861395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Compounds useful for inhibition of farnesyl proteins transferase' [patent_app_type] => 1 [patent_app_number] => 8/927469 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23825 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 916 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861395.pdf [firstpage_image] =>[orig_patent_app_number] => 927469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966692 [patent_doc_number] => 05885996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Antiproliferative quinazolines' [patent_app_type] => 1 [patent_app_number] => 8/923117 [patent_app_country] => US [patent_app_date] => 1997-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 588 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885996.pdf [firstpage_image] =>[orig_patent_app_number] => 923117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051388 [patent_doc_number] => 05932521 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Herbicidal 1,3-oxazin-4-one derivatives and intermediates thereto' [patent_app_type] => 1 [patent_app_number] => 8/898402 [patent_app_country] => US [patent_app_date] => 1997-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10690 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932521.pdf [firstpage_image] =>[orig_patent_app_number] => 898402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775678 [patent_doc_number] => 05756754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds' [patent_app_type] => 1 [patent_app_number] => 8/878876 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21093 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756754.pdf [firstpage_image] =>[orig_patent_app_number] => 878876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809621 [patent_doc_number] => 05811433 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => '1,6-naphthyridonecarboxylic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/878683 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14780 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811433.pdf [firstpage_image] =>[orig_patent_app_number] => 878683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825629 [patent_doc_number] => 05731307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Neuroleptic 2,7-disubtituted perhydro-1h-pyrido›1, 2-A!pyrazines' [patent_app_type] => 1 [patent_app_number] => 8/809903 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4947 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731307.pdf [firstpage_image] =>[orig_patent_app_number] => 809903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833523 [patent_doc_number] => 05814631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Quinazoline derivatives and applications thereof' [patent_app_type] => 1 [patent_app_number] => 8/849114 [patent_app_country] => US [patent_app_date] => 1997-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33628 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 376 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814631.pdf [firstpage_image] =>[orig_patent_app_number] => 849114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783431 [patent_doc_number] => 05821246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Aniline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/836362 [patent_app_country] => US [patent_app_date] => 1997-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36816 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821246.pdf [firstpage_image] =>[orig_patent_app_number] => 836362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3776887 [patent_doc_number] => 05756832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring' [patent_app_type] => 1 [patent_app_number] => 8/853398 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44425 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756832.pdf [firstpage_image] =>[orig_patent_app_number] => 853398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770623 [patent_doc_number] => 05849742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/853239 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15518 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849742.pdf [firstpage_image] =>[orig_patent_app_number] => 853239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828362 [patent_doc_number] => 05760039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Lyophilized composition containing S(+)-4,4\'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)' [patent_app_type] => 1 [patent_app_number] => 8/827676 [patent_app_country] => US [patent_app_date] => 1997-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4573 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760039.pdf [firstpage_image] =>[orig_patent_app_number] => 827676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3817072 [patent_doc_number] => 05770603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/871989 [patent_app_country] => US [patent_app_date] => 1997-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8748 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770603.pdf [firstpage_image] =>[orig_patent_app_number] => 871989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051092 [patent_doc_number] => 05869665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Quinazolinone derivatives as cholecystokinin (CCK) ligands' [patent_app_type] => 1 [patent_app_number] => 8/826843 [patent_app_country] => US [patent_app_date] => 1997-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869665.pdf [firstpage_image] =>[orig_patent_app_number] => 826843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809126 [patent_doc_number] => 05831090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Process for the preparation of photochromic compounds of the annelated spiro›indoline›2,3\'! benzoxazine!type' [patent_app_type] => 1 [patent_app_number] => 8/776046 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4481 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831090.pdf [firstpage_image] =>[orig_patent_app_number] => 776046 [rel_patent_id] =>[rel_patent_doc_number] =>)